Last €112.16 EUR
Change Today +0.153 / 0.14%
Volume 8.3M
BAYN On Other Exchanges
Symbol
Exchange
OTC US
Xetra
OTC US
BrsaItaliana
Xetra
Mexico
Continuous
As of 1:55 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

bayer ag-reg (BAYN) Snapshot

Open
€112.55
Previous Close
€112.01
Day High
€113.95
Day Low
€111.99
52 Week High
09/19/14 - €113.95
52 Week Low
10/9/13 - €83.72
Market Cap
92.8B
Average Volume 10 Days
1.7M
EPS TTM
€4.31
Shares Outstanding
826.9M
EX-Date
04/30/14
P/E TM
26.0x
Dividend
€2.10
Dividend Yield
1.87%
Current Stock Chart for BAYER AG-REG (BAYN)

bayer ag-reg (BAYN) Related Bloomberg News

View More Bloomberg News

bayer ag-reg (BAYN) Details

Bayer Aktiengesellschaft develops, produces, and markets health care and agricultural products, and high-tech polymer materials worldwide. The company operates through HealthCare, CropScience, and MaterialScience segments. The HealthCare segment offers prescription pharmaceuticals, such as contraceptives, hemophilia treatments, anticoagulants, and medicines to treat multiple sclerosis, cancer, hypertension, and infectious diseases; and consumer health products comprising over-the-counter medications, dermatology products, nutritional supplements, veterinary medicines, and animal grooming products. This segment also provides medical care products, including blood glucose monitoring devices, such as single-strip and multi-strip systems; USB meters that feature integrated diabetes management software and direct plug-in to computers; contrast agent injection systems for diagnostic and therapeutic medical procedures in computed tomography, magnetic resonance imaging, and molecular imaging; and mechanical systems for removing thrombi from blood vessels, as well as service products for its systems. The CropScience segment offers products for use in agriculture as insecticides, fungicides, and herbicides or seed treatments; seeds and plant traits; and various products for gardens, green industry, and nonagricultural pest control. The MaterialScience segment provides high-tech polymer materials in the areas of polyurethanes, polycarbonates, coating and adhesive raw materials, and functional films; and produces and markets inorganic basic chemicals. The company has a strategic alliance with OncoMed Pharmaceuticals, Inc. to develop drugs to target cancer stem cell therapeutics. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

115,487 Employees
Last Reported Date: 07/29/14
Founded in 1863

bayer ag-reg (BAYN) Top Compensated Officers

Chairman of Management Board and Chief Execut...
Total Annual Compensation: €2.9M
Chief Financial Officer and Member of Managem...
Total Annual Compensation: €1.8M
Labor Director and Member of Management Board
Total Annual Compensation: €1.1M
Compensation as of Fiscal Year 2013.

bayer ag-reg (BAYN) Key Developments

Bayer Considers to Sell Bayer MaterialScience

The executive Board of Bayer AG (DB:BAYN) might consider selling Bayer MaterialScience AG, but its intention is to either spin off or launch an IPO on the German stock exchange, said Chief Executive Officer, Marijn Dekkers.

Bayer Intends To Float Its Chemical Division

Bayer AG (DB:BAYN) intends to float its chemicals material science division to focus on its life sciences activities in human and animal health. Bayer said that the decision, taken at the beginning of the month, will be discussed by the supervisory Board at its meeting, Thursday, September 18, 2014.

Bayer To Split Off Polymer Division With IPO

Bayer AG (DB:BAYN) plans to spin off its polymer division with a separate stock listing. Bayer would use proceeds from the sale to invest in its life sciences business or reduce debt, or both.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYN:GR €112.16 EUR +0.153

BAYN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GlaxoSmithKline PLC 1,449 GBp +12.50
Merck & Co Inc $60.62 USD +0.31
Pfizer Inc $30.41 USD -0.175
Roche Holding AG SFr.283.20 CHF -0.10
Sanofi €88.76 EUR +0.30
View Industry Companies
 

Industry Analysis

BAYN

Industry Average

Valuation BAYN Industry Range
Price/Earnings 24.7x
Price/Sales 2.2x
Price/Book 4.5x
Price/Cash Flow 24.7x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-REG, please visit www.bayer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.